dr.bambang sympo-1.pdf
TRANSCRIPT
8/18/2019 dr.Bambang sympo-1.pdf
http://slidepdf.com/reader/full/drbambang-sympo-1pdf 1/32
Cardiogenic Shock & MechanicComplications of Myocard Infar
NADIAR DWI NUARISA
BAMBANG HERWANTO
Department of Cardiology & Vascular MedicineDr. Sutomo Hospital – Faculty of Medicine Airlangga Un
Surabaya
2015
8/18/2019 dr.Bambang sympo-1.pdf
http://slidepdf.com/reader/full/drbambang-sympo-1pdf 2/32
Introduction
Definition
•Ventricular Septal Rupture (VSR)
•Acute Mitral Regurgitation
•LV Free Wall Rupture
Mechanical Complication of AMI
Management of Cardiogenic Shock in AMI
Prognosis
Summary
8/18/2019 dr.Bambang sympo-1.pdf
http://slidepdf.com/reader/full/drbambang-sympo-1pdf 3/32
Introduction Worldwide, coronary artery disease (CAD) is the single most freq
of death. Over seven million people every year die from CAD
Cardiogenic shock is a serious complication of acute myocardia
(AMI). Mortality is about 50%.
The mechanical complications of AMI are responsible for approx
25,000 deaths per year in the US.
Since the introduction of PCI, the incidence of mechanical com
reduced significantly to < 1%
Surgical evaluation should be performed early whenever there is
of a mechanical complication
8/18/2019 dr.Bambang sympo-1.pdf
http://slidepdf.com/reader/full/drbambang-sympo-1pdf 4/32
Definition (WHO)
The definition was based on patient symptoms and ECG
findings Combination of two of three characteristics:
1. typical symptoms (i.e. chest discomfort)
2. enzyme rise
3. typical ECG pattern involving the development of Q
waves
But still myocardial infarction was mainly an ECG baseddiagnosis
8/18/2019 dr.Bambang sympo-1.pdf
http://slidepdf.com/reader/full/drbambang-sympo-1pdf 5/32
Definition of Cardiogenic Shock
Is a clinical condition of inadequate tissue (end-organ)perfusion due to cardiac dysfunction
- hypotension ( SBP<90mmHg for 30 min, or the need fosupportive measures to maintain SBP≥90mmHg), fall ofMAP 30mmHg from baseline
- end-organ hypoperfusion (cool extremities or an urineoutput<30 ml/h)
- a cardiac index (CI) < 1,8 l/m/m2 or < 2.2 l/min/m2with haemodynamic support, and a pulmonarycapillary wedge pressure (PCWP)> 18 mmHg
8/18/2019 dr.Bambang sympo-1.pdf
http://slidepdf.com/reader/full/drbambang-sympo-1pdf 6/32
Mechanical Complication of MI
Ventricular Septal Rupture (VSR) VSR is lethal complication of acute myocardial infarctio
(AMI)
Expected to occur within 16 hours after AMI. Theoutcome are poor
Independent risk factors for VSR : hypertension, olderage, female gender, history of previous stroke, CKD, CHdiabetes, smoking, & previous MI.
VSR direct effect is the shunting of blood from LV to RV →cardiogenic shock
8/18/2019 dr.Bambang sympo-1.pdf
http://slidepdf.com/reader/full/drbambang-sympo-1pdf 7/32
On physical examination we can found pansystolic loud m
sounds most clearly at the left edge of the sternum, palpaparasternal thrill
ECG recordings showed anterior or inferior STEMI with AV b
Doppler echocardiography is the gold standard for diagndistinguish between papillary muscle rupture and VSR, assLV function, identified size & site of rupture
8/18/2019 dr.Bambang sympo-1.pdf
http://slidepdf.com/reader/full/drbambang-sympo-1pdf 8/32
Management of VSR (Jones et al, European Heart Journa
8/18/2019 dr.Bambang sympo-1.pdf
http://slidepdf.com/reader/full/drbambang-sympo-1pdf 9/32
VSR Surgery
8/18/2019 dr.Bambang sympo-1.pdf
http://slidepdf.com/reader/full/drbambang-sympo-1pdf 10/32
Acute MR Acute mitral regurgitation secondary to papillary muscle
rupture is a life-threatening complication with a poorprognosis
Usually diagnosed in 2 to 7 days post-AMI, the average
time is approximately 13 hours. Papillary muscle rupture can be partially (occurring at
one end of the muscle) or complete.
Differential diagnosis of VSR → distinguished by a site ofthe murmur & by Swan-Ganz catheter
8/18/2019 dr.Bambang sympo-1.pdf
http://slidepdf.com/reader/full/drbambang-sympo-1pdf 11/32
Pansystolic murmur loudest at the apex, with diastoliccomponents, and spread to the axilla.
ECG describe myocardial infarction posterior or inferior
Doppler Echocardiography is a standard for thediagnosis, monitoring, and planning surgical therapy.
In an acute atmosphere, shock cardiogenic andpulmonary edema may occur → not enough time forthe LV to dilate or compensation
8/18/2019 dr.Bambang sympo-1.pdf
http://slidepdf.com/reader/full/drbambang-sympo-1pdf 12/32
Mitral valve repair & Mitral vareplacement
Management of Acute MR
8/18/2019 dr.Bambang sympo-1.pdf
http://slidepdf.com/reader/full/drbambang-sympo-1pdf 13/32
LV Free Wall Rupture (LVFWR) 50% patients with LVFWR is diagnosed in 5 days post-AM
where 20% of them within 2 weeks.
Risk factors : age, female gender, HT, first AMI, & poorcollateral coronary artery
Blow-out ruptures are manifested with cardiogenicshock (arterial pressure < 70 mmHg for at least 10minutes)
8/18/2019 dr.Bambang sympo-1.pdf
http://slidepdf.com/reader/full/drbambang-sympo-1pdf 14/32
ECG might manifest with increase of ST elevation by atleast 1mV in affected leads, ST elevation in aVL, non-inversion of the T wave
Pericardial effusion is the most commonechocardiographic finding.
Doppler echocardiography may appear as adiscontinuity of the myocardium & bidirectional shunt
8/18/2019 dr.Bambang sympo-1.pdf
http://slidepdf.com/reader/full/drbambang-sympo-1pdf 15/32
Management of LV(Hellenic Journal of 2002)
8/18/2019 dr.Bambang sympo-1.pdf
http://slidepdf.com/reader/full/drbambang-sympo-1pdf 16/32
LVFWR Surgery
8/18/2019 dr.Bambang sympo-1.pdf
http://slidepdf.com/reader/full/drbambang-sympo-1pdf 17/32
Management of Cardiogenic Shock in A
The aim of initial resuscitation is to stabilize oxygenation &perfusion while revascularization is contemplated
We should prepare :
1. DC shock
2. Drugs : inotropes & vasopressors
3. Reperfusion strategies : the trombolytic therapy,
percutaneous coronary intervention (PCI), surgical
(CABG)
4. Mechanical circulatory support : IABP (Intraaortic Balloon
Pump Counterpulsation), extracorporeal membraneoxygenation (ECMO), percutaneus Ventricular Assist
Devices/pVAD (Impella recover system, Tandem heart)
8/18/2019 dr.Bambang sympo-1.pdf
http://slidepdf.com/reader/full/drbambang-sympo-1pdf 18/32
Algorism for the management of ischemic cardiogenic shock (Reynolds & Hoc
8/18/2019 dr.Bambang sympo-1.pdf
http://slidepdf.com/reader/full/drbambang-sympo-1pdf 19/32
IABP
8/18/2019 dr.Bambang sympo-1.pdf
http://slidepdf.com/reader/full/drbambang-sympo-1pdf 20/32
ECMO
8/18/2019 dr.Bambang sympo-1.pdf
http://slidepdf.com/reader/full/drbambang-sympo-1pdf 21/32
TandemHeart
8/18/2019 dr.Bambang sympo-1.pdf
http://slidepdf.com/reader/full/drbambang-sympo-1pdf 22/32
Impella recovery system
8/18/2019 dr.Bambang sympo-1.pdf
http://slidepdf.com/reader/full/drbambang-sympo-1pdf 23/32
Prognosis
VSR
Patients treated medically have poor overall prognosis,with a mortality rate of 24% in 24 hours, 46% in 1 week,and 82% mortality within 2 months.
Mortality after surgery is 42,9%.
54,1% mortality patient underwent surgery within 7 daysafter MI higher than patients who underwent surgery atmore than 7 days (mortality rate 18,4%).
The highest mortality rate (> 60%) in patients whounderwent surgery in the first 24 hours
8/18/2019 dr.Bambang sympo-1.pdf
http://slidepdf.com/reader/full/drbambang-sympo-1pdf 24/32
Acute MR
Only 25% patients survive acute MR 24 hours after therupture of papillary muscle.
The average survival of patients without surgery just thredays
In one study, 5126 patients who underwent surgicalintervention, the mortality rate was 26,9% with a 15-yearsurvival of 39%
LVFWR
Operative mortality of LVFWR between 12% to 30%.
Long-term outcome of these patients is the survival of 7years.
8/18/2019 dr.Bambang sympo-1.pdf
http://slidepdf.com/reader/full/drbambang-sympo-1pdf 25/32
Summary
The 3 most often mechanical complications after IMAare ventricular septal rupture (VSR), acute mitralregurgitation, and LV Free Wall Rupture (LVFWR)
This resulted in cardiogenic shock and require surgicaltreatment.
The mortality rate of each complication is still high, aftersurgery or without surgery.
8/18/2019 dr.Bambang sympo-1.pdf
http://slidepdf.com/reader/full/drbambang-sympo-1pdf 26/32
8/18/2019 dr.Bambang sympo-1.pdf
http://slidepdf.com/reader/full/drbambang-sympo-1pdf 27/32
8/18/2019 dr.Bambang sympo-1.pdf
http://slidepdf.com/reader/full/drbambang-sympo-1pdf 28/32
8/18/2019 dr.Bambang sympo-1.pdf
http://slidepdf.com/reader/full/drbambang-sympo-1pdf 29/32
Guideline Recommendation of Assist Devices According to ESC & AHA
8/18/2019 dr.Bambang sympo-1.pdf
http://slidepdf.com/reader/full/drbambang-sympo-1pdf 30/32
Algorism for Revascularization in cardiogenic shock (ACC/AHA Guideline
8/18/2019 dr.Bambang sympo-1.pdf
http://slidepdf.com/reader/full/drbambang-sympo-1pdf 31/32
8/18/2019 dr.Bambang sympo-1.pdf
http://slidepdf.com/reader/full/drbambang-sympo-1pdf 32/32
Definition of AMI (ESC 2012)
The term AMI should be used when there is evidence of
myocardial necrosis in a clinical setting consistent with
myocardial ischaemia.
Detection of rise and/or fall of cardiac biomarker values with
at least one of the following:
- Symptoms of ischaemia
- New or presumably new significant ST-T changes or new
LBBB
- Development of pathological Q waves in the ECG
- Imaging evidence of new loss of viable myocardium, or
new regional wall motion abnormality
- Identification of an intracoronary thrombus by angiograph
or autopsy